Back

Zuneca Pharmaceutical vs. Natrapharm, Inc. [CONCURRING OPINION, PERLAS-BERNABE, J.]

ZUNECA PHARMACEUTICAL, AKRAM ARAIN AND/OR VENUS ARAIN, M.D., AND STYLE OF ZUNECA PHARMACEUTICAL, PETITIONERS, VS. NATRAPHARM, INC., RESPONDENT.

G.R. No. 211850 | 2020-09-08

CONCURRING OPINION
 
PERLAS-BERNABE, J.:

I concur. Petitioner Zuneca Pharmaceutical, et al. (Zuneca) should be considered as a prior user in good faith of the trademark "ZYNAPS" under the auspices of Section 159.1 (or "prior user in good faith rule") of Republic Act No. (RA) 8293,[1] otherwise known as the "Intellectual Property Code." The provision states:

 
SECTION 159. Limitations to Actions for Infringement. - Notwithstanding any other provision of this Act, the remedies given to the owner of a right infringed under this Act shall be limited as follows:
 
159.1. ...